Cassie Ray Springer, PA-C | |
206 Alaska Frontage Rd, Belgrade, MT 59714-7909 | |
(406) 414-3334 | |
Not Available |
Full Name | Cassie Ray Springer |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 206 Alaska Frontage Rd, Belgrade, Montana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508199548 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MED-PAC-LIC-651 (Montana) | Secondary |
363A00000X | Physician Assistant | 4490 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cassie Ray Springer, PA-C 206 Alaska Frontage Rd, Belgrade, MT 59714-7909 Ph: (406) 414-3334 | Cassie Ray Springer, PA-C 206 Alaska Frontage Rd, Belgrade, MT 59714-7909 Ph: (406) 414-3334 |
News Archive
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant predictor of metastasis in patients treated with postoperative salvage radiation therapy.
AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.
Researchers in the United Kingdom have set up a "living" systematic review in response to the rapidly emerging evidence-base for "long COVID" – the term used to refer to coronavirus disease 2019 (COVID-19) symptoms that persist for longer than would usually be expected.
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
› Verified 4 days ago